Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 13.90 Delayed Data As of Oct 23 |  -0.15 / -1.07%Today’s Change | 10.75 Today|||52-Week Range 19.90 | -7.64% Year-to-Date |
| Previous close | 14.05 |
| Today’s open | 14.05 |
| Day’s range | 13.85 - 14.15 |
| Volume | 611,210 |
| Average volume (3 months) | 750,294 |
| Market cap | $1.1B |
| Dividend yield | -- |
| Earnings growth (last year) | +76.52% |
| Earnings growth (this year) | -295.69% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +22.27% |
| P/E ratio | NM |
| Price/Sales | 9.43 |
| Price/Book | 2.69 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGMOSangamo Therapeutics... | +0.15 | +1.12% |
| XLRNAcceleron Pharma Inc | -0.10 | -0.27% |
| ---- | ||
| EPZMEpizyme Inc | -0.55 | -3.23% |
| Next reporting date | November 8, 2017 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $109.6M |
| Annual profit (last year) | -$21.0M |
| Net profit margin | -19.16% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Craig A. Wheeler |
Chief Operating Officer & Chief Scientific Officer Ganesh Venkataraman Kaundinya |
Corporate headquarters Cambridge, Massachusetts |
